Science & Enterprise subscription

Follow us on Twitter

  • A New England hospital system is assessing with real patients a point-of-care test for Covid-19 viruses that return… https://t.co/kdaawxTrOU
    about 8 hours ago
  • New post on Science and Enterprise: Hospitals Testing Fast Covid-19 Diagnostic https://t.co/Ou6Fk0L4Yb #Science #Business
    about 8 hours ago
  • Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sighte… https://t.co/fJkqvINR8w
    about 14 hours ago
  • New post on Science and Enterprise: Muti-Focus Contact Lenses Slow Children’s Myopia https://t.co/mWV1LNbHOW #Science #Business
    about 14 hours ago
  • Could?? ... How Russia’s Rushed Covid-19 Vaccine Could Backfire https://t.co/Sqt4P3jllE
    about 18 hours ago

Please share Science & Enterprise

Muti-Focus Contact Lenses Slow Children’s Myopia

Contact lens

Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sightedness in children. . . . → Read More: Muti-Focus Contact Lenses Slow Children’s Myopia

Trial Testing Rare Disease Drug for Covid-19 Pneumonia

Human lungs illustration

A clinical trial is underway assessing a drug approved for a rare inherited disease as a treatment for people hospitalized with pneumonia from Covid-19 infections. . . . → Read More: Trial Testing Rare Disease Drug for Covid-19 Pneumonia

Covid-19 Vaccines, Therapies – 10 August 2020

Covid-19 vaccine and therapy tracker

Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinical trials now totaling 41. . . . → Read More: Covid-19 Vaccines, Therapies – 10 August 2020

Grant Funds Placenta Stem Cell Trial Sites for Covid-19

Pregnant woman

A clinical trial testing stem cells from human placentas as a treatment for Covid-19 infections is expanding to three more sites in California. . . . → Read More: Grant Funds Placenta Stem Cell Trial Sites for Covid-19

NIH Begins Covid-19 Antibody Trials

Global Covid-19

National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe. . . . → Read More: NIH Begins Covid-19 Antibody Trials

UCLA, Apple Partner on Depression Study

Apple Watch

Researchers from University of California in Los Angeles and Apple Corp. are beginning a study of wearable and home technologies to detect depression. . . . → Read More: UCLA, Apple Partner on Depression Study

Trial Set for Covid-19 Antibodies in Long-Term Care

Mobile lab team

Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care. . . . → Read More: Trial Set for Covid-19 Antibodies in Long-Term Care

Covid-19 Vaccines, Therapies – 3 August 2020

Vaccine and therapy tracker

The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 and 35 respectively. . . . → Read More: Covid-19 Vaccines, Therapies – 3 August 2020

Trial Underway for Seasonal Flu Antibody Therapy

Cattle

A participant in an early-stage clinical trial received the first dose of an experimental synthetic antibody produced in cattle to treat seasonal influenza. . . . → Read More: Trial Underway for Seasonal Flu Antibody Therapy

Trial Testing Lymphoma Drug to Treat Covid-19

SARS-Cov-2 virus

A clinical trial is underway testing an experimental drug for lymphoma and neurological disorders also as a treatment for early Covid-19 infections. . . . → Read More: Trial Testing Lymphoma Drug to Treat Covid-19